Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study.
Phillips AN, Venter F, Havlir D, Pozniak A, Kuritzkes D, Wensing A, Lundgren JD, De Luca A, Pillay D, Mellors J, Cambiano V, Bansi-Matharu L, Nakagawa F, Kalua T, Jahn A, Apollo T, Mugurungi O, Clayden P, Gupta RK, Barnabas R, Revill P, Cohn J, Bertagnolio S, Calmy A. Phillips AN, et al. Among authors: kuritzkes d. Lancet HIV. 2019 Feb;6(2):e116-e127. doi: 10.1016/S2352-3018(18)30317-5. Epub 2018 Nov 29. Lancet HIV. 2019. PMID: 30503325 Free PMC article.
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.
Hirsch MS, Conway B, D'Aquila RT, Johnson VA, Brun-Vézinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM, Kuritzkes DR, Loveday C, Mellors JW, Vella S, Richman DD. Hirsch MS, et al. Among authors: d aquila rt, kuritzkes dr. JAMA. 1998 Jun 24;279(24):1984-91. doi: 10.1001/jama.279.24.1984. JAMA. 1998. PMID: 9643863 Review.
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.
Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, Richman DD. Hirsch MS, et al. Among authors: d aquila rt, kuritzkes dr. Clin Infect Dis. 2003 Jul 1;37(1):113-28. doi: 10.1086/375597. Epub 2003 Jun 23. Clin Infect Dis. 2003. PMID: 12830416
Update of the Drug Resistance Mutations in HIV-1: 2005.
Johnson VA, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, Pillay D, Schapiro J, Telenti A, Richman D. Johnson VA, et al. Among authors: kuritzkes dr. Top HIV Med. 2005 Mar-Apr;13(1):51-7. Top HIV Med. 2005. PMID: 15849371 Free article. Review.
Update of the drug resistance mutations in HIV-1: Fall 2006.
Johnson VA, Brun-Vezinet F, Clotet B, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. Johnson VA, et al. Among authors: kuritzkes dr. Top HIV Med. 2006 Aug-Sep;14(3):125-30. Top HIV Med. 2006. PMID: 16946457 Free article.
Update of the drug resistance mutations in HIV-1: 2007.
Johnson VA, Brun-Vézinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. Johnson VA, et al. Among authors: kuritzkes dr. Top HIV Med. 2007 Aug-Sep;15(4):119-25. Top HIV Med. 2007. PMID: 17720996 Free article. Review. No abstract available.
437 results